Intrexon | DŁUG





DŁUG Zmiana Data
Agenus USD 35.54M 2.34M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 54.59B 1.62B 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Incyte USD 40.41M 855K 2025-12
Intrexon USD 0 13.82M 2024-06
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
MacroGenics USD 37.01M 238K 2025-09
MannKind USD 119.91M 73.09M 2025-09
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Thermo Fisher Scientific USD 35.68B 451M 2025-09
Veracyte USD 40.45M 10.19M 2025-09
Xencor USD 69.27M 1.34M 2025-09


Intrexon DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.